Researchers at the University of Chicago identified a mechanism to make immune cells reprogrammed by radiation therapy attack tumors rather than protect them.

For decades, scientists have known that a protein made by T cells and natural killer (NK) cells in the immune system, called perforin, can kill tumor cells by punching a hole in the cell wall and injecting proteases called granzymes, which kill the cell.

Three Drugs, One Remarkable Breakthrough. Cancer May Have Met Its Match. British researchers have discovered that combining three existing cancer treatments could dramatically shrink some of the most ...

The Moderna-Merck mRNA cancer vaccine helps prevent cancer recurrence and death, the new results show

Cancer treatment can change more than your appearance. From hair loss, surgical scars and changes in weight to altered sensation, sexuality and intimacy, the experience can leave you feeling…

Advances in genetic testing and clinical research are giving physicians new ways to select breast cancer treatments based on individual patients’ needs, according to Dr. Joseph Murray, senior medical director at Caris Life Sciences

An analysis released Friday by Democrats on the congressional Joint Economic Committee details how US President Donald Trump loaded up on shares of major pharmaceutical companies last year as his admi...

Patients and clinicians alike are witnessing a revolutionary transition in drug delivery. By shifting from traditional IV infusions to subcutaneous formulations, treatments that once consumed a full d...

ROME, Italy - Pope Leo XIV celebrated Mass at Rome’s Gemelli Hospital on October 16, three days after surgery to

Visit showcases how Niowave’s advanced manufacturing workforce is leading the next generation of scientific innovation and cancer treatment. LANSING, Mich., Oct. 16, 2026 /PRNewswire/ — Yesterday, Niowave welcomed Labor Secretary Keith Sonderling for a tour of the company’s operations and a first-hand look at progress on the construction of its new medical radioisotope production facility. Secretary Sonderling toured Niowave’s current dedicated production facility as well as the construction site for its second, and held a roundtable with Niowave leaders, who detailed the company’s production of medical radioisotopes for next-generation cancer treatments. Discussions also covered how the new facility will expand […]